| Date | Source | Headline | |
|---|---|---|---|
| 12th Mar 2026 | 6:00 am | RNS-R | MindMaze Therapeutics Appoints HealthTech Veteran Zach Henderson as CEO to Accelerate Global Commercial Scale |
| 23rd Dec 2025 | 6:00 am | RNS-R | MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics |
Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.
To access our Live RNS you must confirm you are a private investor by using the button below.